Altamira Therapeutics Ltd. (CYTOF): 6-K filed Mar 10, 2025

Form type

6-K

Filing date

Mar 10, 2025

Accession number

0001213900-25-022236

Filer

Altamira Therapeutics Ltd. (CIK 1601936)